Globe Life trades at $148.19 and has moved in lockstep with the market. Its shares have returned 7.3% over the last six months while the S&P 500 has gained 3.1%.

Is now the time to buy Globe Life, or should you be careful about including it in your portfolio? Dive into our full research report to see our analyst team’s opinion, it’s free.

Why Is Globe Life Not Exciting?

We don't have much confidence in Globe Life. Here are three reasons you should be careful with GL and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

Big picture, insurers generate revenue from three key sources. The first is the core business of underwriting policies. The second source is income from investing the “float” (premiums collected upfront not yet paid out as claims) in assets such as fixed-income assets and equities. The third is fees from various sources such as policy administration, annuities, or other value-added services.

Regrettably, Globe Life’s revenue grew at a tepid 4.9% compounded annual growth rate over the last five years. This was below our standard for the insurance sector.

2. Net Premiums Earned Point to Soft Demand

When insurers sell policies, they protect themselves from extremely large losses or an outsized accumulation of losses with reinsurance (insurance for insurance companies). Net premiums earned are:

• Gross premiums - what’s ceded to reinsurers as a risk mitigation and transfer strategy

Globe Life’s net premiums earned has grown at a 4.8% annualized rate over the last two years, worse than the broader insurance industry and in line with its total revenue.

3. Growing BVPS Reflects Strong Asset Base

Book value per share (BVPS) serves as a key indicator of an insurer’s financial stability, reflecting a company’s ability to maintain adequate capital levels and meet its long-term obligations to policyholders.

Although Globe Life’s BVPS declined at a 2.2% annual clip over the last five years. the good news is that its growth inflected positive over the past two years as BVPS grew at an incredible 25.7% annual clip (from $47.84 to $75.54 per share).

Final Judgment

Globe Life isn’t a terrible business, but it doesn’t pass our bar. That said, the stock currently trades at 1.7× forward P/B (or $148.19 per share). This valuation multiple is fair, but we don’t have much faith in the company. We're fairly confident there are better investments elsewhere. We’d suggest looking at a fast-growing restaurant franchise with an A+ ranch dressing sauce.

Stocks We Like More Than Globe Life

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.